InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Dickinson Andrew D, Chief Financial Officer. Insider active across 2 companies, notably Gilead Sciences, INC.. Aggregated, 60 reports have been logged. Split: 0 buy · 23 sells. Total volume traded: €7m. History available since 15 August 2021. The latest transaction was filed on 17 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Dickinson Andrew D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
3,000 shares@ US$138.36Common StockSEC:0001310204-26-000024:0
3,000 shares@ US$129.92560.0002% mcap2.3% of flowCommon StockSEC:0001310204-26-000022:0
3,000 sharesCommon StockSEC:0001310204-26-000020:0
2,796 sharesCommon StockSEC:0001310204-26-000018:0
1,341 sharesCommon StockSEC:0001310204-26-000018:1
3,000 shares@ US$140.960.0002% mcap7.1% of flowCommon StockSEC:0001310204-26-000014:0
3,000 shares@ US$144.230.0002% mcap7.5% of flowCommon StockSEC:0001310204-26-000012:0
6,469 sharesCommon StockSEC:0001310204-26-000010:0
11,090 shares0Common StockSEC:0001310204-26-000008:0
3,000 shares@ US$154.430.0002% mcap7.8% of flowCommon StockSEC:0001310204-26-000006:0
44,867 shares0Common StockSEC:0001310204-26-000004:0
3,000 shares@ US$124.310.0002% mcap6.4% of flowCommon StockSEC:0001310204-26-000002:0
3,000 shares@ US$122.000.0002% mcap6.2% of flowCommon StockSEC:0001310204-25-000021:0
3,693 sharesCommon StockSEC:0001310204-25-000019:0
2,500 shares@ US$125.231.9% of flowCommon StockSEC:0001310204-25-000017:0
2,500 shares@ US$118.080.0002% mcap5.0% of flowCommon StockSEC:0001310204-25-000014:0
2,500 shares@ US$113.570.0002% mcap4.8% of flowCommon StockSEC:0001310204-25-000011:0
3,696 sharesCommon StockSEC:0001310204-25-000007:0
2,500 shares@ US$118.530.0002% mcap5.1% of flowCommon StockSEC:0001310204-25-000005:0
2,500 shares@ US$111.031.7% of flowCommon StockSEC:0001127602-25-019286:0
2,500 shares@ US$110.171.7% of flowCommon StockSEC:0001127602-25-017692:0
3,694 sharesCommon StockSEC:0001127602-25-017331:0
2,500 shares@ US$99.821.4% of flowCommon StockSEC:0001127602-25-014718:0
2,500 shares@ US$106.401.5% of flowCommon StockSEC:0001127602-25-012101:0
2,500 shares@ US$110.531.6% of flowCommon StockSEC:0001127602-25-009796:0
25 of 60 declarations
About Dickinson Andrew D
Dickinson Andrew D is Directeur Financier and Chief Financial Officer at Gilead Sciences, INC. and Gilead Sciences INC. The declarant has 58 filings in total, and in the sampled filings the activity spans from 2021-06-14 to 2026-06-16, with EUR 0 of purchases and EUR 6311014 of sales, the most frequent transaction type being Levée d'options.
